Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunshine Lake Pharma CoHKSE:06887 +1.61%15 FCF Margin % is 34.11% as of Dec. 2025, which is 701% above its 10-year median of 4.26. GuruFocus rates HKSE:06887 with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 959 Drug Manufacturers companies, Sunshine Lake Pharma Co ranks better than 57.56% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sunshine Lake Pharma Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunshine Lake Pharma Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sunshine Lake Pharma Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Sunshine Lake Pharma Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunshine Lake Pharma Co (HKSE:06887) has a FCF Margin % of 34.11% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sunshine Lake Pharma Co and its competitors. This is 701% above median its historical median of 4.26. According to the industry distribution chart, Sunshine Lake Pharma Co ranks #407 out of 959 companies in the Drug Manufacturers industry, placing it in the top 42.4%.
Is Sunshine Lake Pharma Co's FCF Margin % too high?
Sunshine Lake Pharma Co's current FCF Margin % of 34.11% is 701% above median its 10-year median of 4.26. The Drug Manufacturers industry median FCF Margin % is 2.40. Sunshine Lake Pharma Co's value of 34.11% is 1321.3% above this industry median. Based on the distribution chart, Sunshine Lake Pharma Co ranks #407 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sunshine Lake Pharma Co has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Sunshine Lake Pharma Co's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sunshine Lake Pharma Co ranks #407 out of 959 companies for FCF Margin %. This puts Sunshine Lake Pharma Co in the upper half of its industry. The industry median FCF Margin % is 2.40. Sunshine Lake Pharma Co's value of 34.11% is 1321.3% above this benchmark. While the company's 10-year median is 4.26 vs. the industry median of 2.40, Sunshine Lake Pharma Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.40, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunshine Lake Pharma Co's current FCF Margin % of 34.11% is 1321.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sunshine Lake Pharma Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunshine Lake Pharma Co's current FCF Margin % is 34.11%, which is 701% above median its own 10-year median of 4.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Lake Pharma Co stock overvalued right now?
Sunshine Lake Pharma Co (HKSE:06887) has a current FCF Margin % of 34.11%. The current FCF Margin % is 34.11%, which is 701% above median its 10-year median of 4.26 and 1321.3% above the Drug Manufacturers industry median of 2.40. Sunshine Lake Pharma Co's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Sunshine Lake Pharma Co (HKSE:06887), the current FCF Margin % is 34.11% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunshine Lake Pharma Co Ltd is a vertically integrated pharmaceutical company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. It is focused on therapeutic areas of infectious diseases, chronic diseases and oncology. The company's revenue is mainly derived from sales of pharmaceutical products to distributors in the PRC.
15GF Score
Get the complete analysis for HKSE:06887
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06887 has been successfully added to your 
